Please find the session links next to their corresponding agenda item.
Thursday, April 28
11:00 AM
FDLI Welcome and Announcements
Enter this session: https://fdli.zoom.us/j/85719864330
11:05 AM– 12:05 PM
FDA’s COVID-19 Activities
Vanessa K. Burrows, Counsel, Simpson Thacher & Bartlett
Enter this session: https://fdli.zoom.us/j/85719864330
12:05 – 12:15 PM
Break
12:15 – 1:15 PM
Regulation of Over-the-Counter (OTC) Drugs
Douglas B. Farquhar, Director, Hyman, Phelps & McNamara, PC
Enter this session: https://fdli.zoom.us/j/82415299124
1:15 – 1:25 PM
Break
1:25 – 2:25 PM
Regulation of Drug Manufacturing
David L. Chesney, Principal and GM, DL Chesney Consulting, LLC
Enter this session: https://fdli.zoom.us/j/84738331516
2:25 – 2:35 PM
Break
2:35 – 3:35 PM
Regulation of Drug Marketing
Alan G. Minsk, Partner, Arnall Golden Gregory LLP
Enter this session: https://fdli.zoom.us/j/84820753094
3:35 – 3:45 PM
Break
3:45 – 5:00 PM
Violations and Enforcement
Frederick R. Ball, Partner, Duane Morris LLP, FDLI Board of Directors
Enter this session: https://fdli.zoom.us/j/82838781413
5:00 PM
Adjournment